MedTrace Logo

TCF7L2 Polymorphisms Influence on Glycemic Control in ICU Patients With Organ Failure

NCT03055169 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 994

Last updated 2026-05-14

No results posted yet for this study

Summary

This study evaluates the link between genetic polymorphisms as r7903146, rs12255372 of TCF7L2 gene and the risk of developing hyperglycemia during Intensive care unit stay

Conditions

  • Genetic Predisposition to Disease
  • Hyperglycemia
  • Intensive Care Unit Syndrome
  • Multiple Organ Failure

Interventions

GENETIC

genetic analysis

BIOLOGICAL

blood and stools samples

Sponsors & Collaborators

  • University Hospital, Lille

    lead OTHER

Principal Investigators

  • Mercedes Jourdain, MD, PhD · University Hospital, Lille

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2016-08-31
Completion
2017-08-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03055169 on ClinicalTrials.gov